<p>NBT Bank N A NY 在最近向美国证券交易委员会（SEC）披露的文件中表示，在第二季度减少了对赛默飞世尔科技公司（NYSE:TMO - 免费报告）股票的持仓，减少幅度为 5.9%。该公司在季度内出售了 598 股后，持有 9,546 股医疗研究公司的股票。NBT Bank N A NY 在赛默飞世尔科技的持股在最近的报告期末价值为 3,871,000 美元。</p>
<ul>
<li>现金流关注：赛默飞世尔、能源转移和网易</li>
</ul>
<p>其他几家对冲基金和机构投资者最近也增加或减少了对该公司的投资。Lakeshore Capital Group Inc. 在第二季度将其在赛默飞世尔科技的持仓增加了 42.7%。Lakeshore Capital Group Inc. 目前持有 1,330 股医疗研究公司的股票，价值为 539,000 美元，此前在该期间又购买了 398 股。Somerville Kurt F 在第二季度将其在赛默飞世尔科技的持仓增加了 1.6%。Somerville Kurt F 目前持有 1,605 股医疗研究公司的股票，价值为 651,000 美元，此前在上个季度又购买了 25 股。REAP Financial Group LLC 在第二季度将其在赛默飞世尔科技的持仓增加了 131.1%。REAP Financial Group LLC 目前持有 104 股医疗研究公司的股票，价值为 42,000 美元，此前在上个季度又购买了 59 股。Sax Wealth Advisors LLC 在第二季度将其在赛默飞世尔科技的持仓增加了 152.6%。Sax Wealth Advisors LLC 目前持有 1,579 股医疗研究公司的股票，价值为 640,000 美元，此前在上个季度又购买了 954 股。最后，WestEnd Advisors LLC 在第二季度将其在赛默飞世尔科技的持仓增加了 28.5%。WestEnd Advisors LLC 目前持有 85,492 股医疗研究公司的股票，价值为 34,665,000 美元，此前在上个季度又购买了 18,950 股。机构投资者和对冲基金目前持有该公司 89.23% 的股票。</p>
<h2>赛默飞世尔科技价格表现</h2>
<p>TMO 的股票在周三开盘价为 539.54 美元。赛默飞世尔科技公司的一年最低价为 385.46 美元，一年最高价为 610.97 美元。该股票的市值为 2037.3 亿美元，市盈率为 31.21，市盈增长比率为 2.95，贝塔值为 0.77。该公司有 50 日简单移动平均线为 484.90 美元，200 日简单移动平均线为 447.60 美元。公司的债务与股本比率为 0.65，流动比率为 1.93，速动比率为 1.50。</p>
<ul>
<li>安捷伦科技受益于对永久性化学品的打击</li>
</ul>
<p>赛默飞世尔科技（NYSE:TMO - 获取免费报告）最近在 7 月 23 日宣布了其季度财报。该医疗研究公司报告季度每股收益为 5.36 美元，超出分析师一致预期的 5.22 美元，超出幅度为 0.14 美元。赛默飞世尔科技的净利润率为 15.24%，股本回报率为 16.82%。该公司在本季度的收入为 108.6 亿美元，而分析师预期为 106.8 亿美元。去年同期，该公司的每股收益为 5.37 美元。本季度的收入同比增长了 2.9%。赛默飞世尔科技已将其 2025 年第三季度的指导目标设定为每股收益 5.460-5.510 美元。2025 财年的指导目标为每股收益 22.220-22.840 美元。整体来看，分析师预测赛默飞世尔科技公司今年将发布 23.28 美元的每股收益。</p>
<h2>赛默飞世尔科技股息公告</h2>
<p>该公司还最近披露了一项季度股息，将于 10 月 15 日（星期三）支付。9 月 15 日（星期一）的股东将获得 0.43 美元的股息。该股息的除息日为 9 月 15 日（星期一）。这代表着每年 1.72 美元的股息和 0.3% 的股息收益率。赛默飞世尔科技的股息支付比率（DPR）目前为 9.95%。</p>
<h2>内部活动</h2>
<ul>
<li>标普 500 中增长最快的 4 个股息：买入、卖出还是持有？</li>
</ul>
<p>在其他新闻中，首席会计官 Joseph R. Holmes 在 8 月 29 日（星期五）出售了 385 股公司的股票。股票以平均价格 492.63 美元出售，总价值为 189,662.55 美元。交易完成后，首席会计官持有 2,319 股公司股票，价值约为 1,142,408.97 美元。这笔交易代表其持股减少了 14.24%。该交易已在向 SEC 提交的文件中披露，相关文件可通过 SEC 网站访问。此外，执行副总裁 Gianluca Pettiti 在 7 月 25 日（星期五）出售了 400 股公司的股票。股票以平均价格 479.98 美元出售，总交易额为 191,992.00 美元。交易完成后，执行副总裁直接持有 22,367 股公司股票，价值约为 10,735,712.66 美元。这笔交易代表其持股减少了 1.76%。该销售的披露信息可以在这里找到。在上个季度，内部人士共出售了 30,066 股公司股票，价值为 14,182,963 美元。公司内部人士目前持有 0.33% 的股票。</p>
<h2>华尔街分析师预测增长</h2>
<p>几位股票研究分析师最近对 TMO 股票发表了评论。William Blair 在 8 月 18 日星期一发布的报告中开始覆盖 Thermo Fisher Scientific 的股票，并给予该公司 “跑赢大盘” 的评级。汇丰全球研究在 7 月 24 日星期四的研究报告中将 Thermo Fisher Scientific 的股票评级从 “强力买入” 下调至 “持有”。富国银行在 7 月 24 日星期四的研究报告中将 Thermo Fisher Scientific 的目标价格从 570.00 美元下调至 565.00 美元，并给予该公司 “增持” 评级。Raymond James Financial 在 7 月 24 日星期四的研究报告中重申了 “跑赢大盘” 的评级，并将 Thermo Fisher Scientific 的目标价格设定为 535.00 美元（上调自 525.00 美元）。最后，瑞银集团在 7 月 24 日星期四的研究报告中将 Thermo Fisher Scientific 的目标价格从 460.00 美元上调至 500.00 美元，并给予该股票 “中性” 评级。十五位投资分析师对该股票给予了买入评级，六位分析师给予了持有评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，共识目标价格为 590.60 美元。</p>
<p><strong>查看我们最新的 TMO 股票报告</strong></p>
<h2>Thermo Fisher Scientific 公司简介</h2>
<p>（免费报告）</p>
<p>Thermo Fisher Scientific Inc 在北美、欧洲、亚太地区及国际市场提供生命科学解决方案、分析仪器、专业诊断、实验室产品和生物制药服务。该公司的生命科学解决方案部门为生物和医学研究、药物和疫苗的发现与生产，以及感染和疾病的诊断提供试剂、仪器和耗材；解决方案包括生物科学、遗传科学和生物生产，服务于制药、生物技术、农业、临床、医疗保健、学术和政府市场。</p>
<h2>精选文章</h2>
<ul>
<li>五只我们更看好的股票，胜过 Thermo Fisher Scientific</li>
<li>上升趋势股票解析：学习如何利用上升趋势进行交易</li>
<li>EA 的 550 亿美元交易引发游戏行业震荡</li>
<li>内部交易解析：它能否影响你的投资选择？</li>
<li>这些是第三季度盈利增长的三个热门行业</li>
<li>内幕交易 - 你需要知道的事项</li>
<li>AMD 可能会在此基础上翻倍——得益于其重磅的 OpenAI 交易</li>
</ul>
<p><strong>想知道其他对 TMO 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 Thermo Fisher Scientific Inc.（NYSE:TMO - 免费报告）的最新 13F 文件和内部交易。</p>
<p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw?x-oss-process=image/auto-orient,1/interlace,1/resize,w_1440,h_1440/quality,q_95/format,jpg" alt="" original-src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw"/></p>
<p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
<h2>你现在应该投资 1000 美元在 Thermo Fisher Scientific 吗？</h2>
<p>在考虑 Thermo Fisher Scientific 之前，你需要听听这个。</p>
<p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Thermo Fisher Scientific 并不在名单上。</p>
<p>虽然 Thermo Fisher Scientific 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
<p>查看这五只股票</p>

赛默飞世尔

<p>NBT Bank N A NY 在第二季度减少了对赛默飞世尔（NYSE:TMO）的持股比例，下降了 5.9%，目前持有 9,546 股，价值 387 万美元。其他机构投资者也调整了他们的持仓，Lakeshore Capital 增加了 42.7% 的持股。赛默飞世尔的股票开盘价为 539.54 美元，市值为 2037.3 亿美元。该公司报告第二季度每股收益为 5.36 美元，超出预期，并宣布季度股息为 0.43 美元，将于 10 月 15 日支付</p>

<p>NBT Bank N A NY lessened its position in shares of Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report) by 5.9% during the 2nd quarter, according to the company in its most recent disclosure with the SEC. The firm owned 9,546 shares of the medical research company's stock after selling 598 shares during the quarter. NBT Bank N A NY's holdings in Thermo Fisher Scientific were worth $3,871,000 at the end of the most recent reporting period.</p>
<div class="lb-trans"><p>NBT Bank N A NY 在最近向美国证券交易委员会（SEC）披露的文件中表示，在第二季度减少了对赛默飞世尔科技公司（NYSE:TMO - 免费报告）股票的持仓，减少幅度为 5.9%。该公司在季度内出售了 598 股后，持有 9,546 股医疗研究公司的股票。NBT Bank N A NY 在赛默飞世尔科技的持股在最近的报告期末价值为 3,871,000 美元。</p>
</div><ul>
<li>Cash Flow Focus: Thermo Fisher, Energy Transfer, and NetEase</li>
</ul>
<div class="lb-trans"><ul>
<li>现金流关注：赛默飞世尔、能源转移和网易</li>
</ul>
</div><p>Several other hedge funds and other institutional investors also recently added to or reduced their stakes in the company. Lakeshore Capital Group Inc. grew its position in Thermo Fisher Scientific by 42.7% during the second quarter. Lakeshore Capital Group Inc. now owns 1,330 shares of the medical research company's stock valued at $539,000 after buying an additional 398 shares during the period. Somerville Kurt F increased its holdings in Thermo Fisher Scientific by 1.6% in the 2nd quarter. Somerville Kurt F now owns 1,605 shares of the medical research company's stock worth $651,000 after acquiring an additional 25 shares in the last quarter. REAP Financial Group LLC increased its holdings in Thermo Fisher Scientific by 131.1% in the 2nd quarter. REAP Financial Group LLC now owns 104 shares of the medical research company's stock worth $42,000 after acquiring an additional 59 shares in the last quarter. Sax Wealth Advisors LLC increased its holdings in Thermo Fisher Scientific by 152.6% in the 2nd quarter. Sax Wealth Advisors LLC now owns 1,579 shares of the medical research company's stock worth $640,000 after acquiring an additional 954 shares in the last quarter. Finally, WestEnd Advisors LLC increased its holdings in Thermo Fisher Scientific by 28.5% in the 2nd quarter. WestEnd Advisors LLC now owns 85,492 shares of the medical research company's stock worth $34,665,000 after acquiring an additional 18,950 shares in the last quarter. Institutional investors and hedge funds own 89.23% of the company's stock.</p>
<div class="lb-trans"><p>其他几家对冲基金和机构投资者最近也增加或减少了对该公司的投资。Lakeshore Capital Group Inc. 在第二季度将其在赛默飞世尔科技的持仓增加了 42.7%。Lakeshore Capital Group Inc. 目前持有 1,330 股医疗研究公司的股票，价值为 539,000 美元，此前在该期间又购买了 398 股。Somerville Kurt F 在第二季度将其在赛默飞世尔科技的持仓增加了 1.6%。Somerville Kurt F 目前持有 1,605 股医疗研究公司的股票，价值为 651,000 美元，此前在上个季度又购买了 25 股。REAP Financial Group LLC 在第二季度将其在赛默飞世尔科技的持仓增加了 131.1%。REAP Financial Group LLC 目前持有 104 股医疗研究公司的股票，价值为 42,000 美元，此前在上个季度又购买了 59 股。Sax Wealth Advisors LLC 在第二季度将其在赛默飞世尔科技的持仓增加了 152.6%。Sax Wealth Advisors LLC 目前持有 1,579 股医疗研究公司的股票，价值为 640,000 美元，此前在上个季度又购买了 954 股。最后，WestEnd Advisors LLC 在第二季度将其在赛默飞世尔科技的持仓增加了 28.5%。WestEnd Advisors LLC 目前持有 85,492 股医疗研究公司的股票，价值为 34,665,000 美元，此前在上个季度又购买了 18,950 股。机构投资者和对冲基金目前持有该公司 89.23% 的股票。</p>
</div><h2>Thermo Fisher Scientific Price Performance</h2>
<div class="lb-trans"><h2>赛默飞世尔科技价格表现</h2>
</div><p>Shares of TMO opened at $539.54 on Wednesday. Thermo Fisher Scientific Inc. has a 1-year low of $385.46 and a 1-year high of $610.97. The stock has a market cap of $203.73 billion, a PE ratio of 31.21, a P/E/G ratio of 2.95 and a beta of 0.77. The firm has a 50-day simple moving average of $484.90 and a two-hundred day simple moving average of $447.60. The company has a debt-to-equity ratio of 0.65, a current ratio of 1.93 and a quick ratio of 1.50.</p>
<div class="lb-trans"><p>TMO 的股票在周三开盘价为 539.54 美元。赛默飞世尔科技公司的一年最低价为 385.46 美元，一年最高价为 610.97 美元。该股票的市值为 2037.3 亿美元，市盈率为 31.21，市盈增长比率为 2.95，贝塔值为 0.77。该公司有 50 日简单移动平均线为 484.90 美元，200 日简单移动平均线为 447.60 美元。公司的债务与股本比率为 0.65，流动比率为 1.93，速动比率为 1.50。</p>
</div><ul>
<li>Agilent Technologies Thrives From the Forever Chemicals Crackdown</li>
</ul>
<div class="lb-trans"><ul>
<li>安捷伦科技受益于对永久性化学品的打击</li>
</ul>
</div><p>Thermo Fisher Scientific (NYSE:TMO - Get Free Report) last announced its quarterly earnings results on Wednesday, July 23rd. The medical research company reported $5.36 earnings per share for the quarter, beating analysts' consensus estimates of $5.22 by $0.14. Thermo Fisher Scientific had a net margin of 15.24% and a return on equity of 16.82%. The business had revenue of $10.86 billion during the quarter, compared to analysts' expectations of $10.68 billion. During the same period last year, the business earned $5.37 earnings per share. The business's revenue for the quarter was up 2.9% on a year-over-year basis. Thermo Fisher Scientific has set its Q3 2025 guidance at 5.460-5.510 EPS. FY 2025 guidance at 22.220-22.840 EPS. As a group, analysts forecast that Thermo Fisher Scientific Inc. will post 23.28 EPS for the current year.</p>
<div class="lb-trans"><p>赛默飞世尔科技（NYSE:TMO - 获取免费报告）最近在 7 月 23 日宣布了其季度财报。该医疗研究公司报告季度每股收益为 5.36 美元，超出分析师一致预期的 5.22 美元，超出幅度为 0.14 美元。赛默飞世尔科技的净利润率为 15.24%，股本回报率为 16.82%。该公司在本季度的收入为 108.6 亿美元，而分析师预期为 106.8 亿美元。去年同期，该公司的每股收益为 5.37 美元。本季度的收入同比增长了 2.9%。赛默飞世尔科技已将其 2025 年第三季度的指导目标设定为每股收益 5.460-5.510 美元。2025 财年的指导目标为每股收益 22.220-22.840 美元。整体来看，分析师预测赛默飞世尔科技公司今年将发布 23.28 美元的每股收益。</p>
</div><h2>Thermo Fisher Scientific Dividend Announcement</h2>
<div class="lb-trans"><h2>赛默飞世尔科技股息公告</h2>
</div><p>The firm also recently disclosed a quarterly dividend, which will be paid on Wednesday, October 15th. Stockholders of record on Monday, September 15th will be paid a $0.43 dividend. The ex-dividend date of this dividend is Monday, September 15th. This represents a $1.72 annualized dividend and a dividend yield of 0.3%. Thermo Fisher Scientific's dividend payout ratio (DPR) is presently 9.95%.</p>
<div class="lb-trans"><p>该公司还最近披露了一项季度股息，将于 10 月 15 日（星期三）支付。9 月 15 日（星期一）的股东将获得 0.43 美元的股息。该股息的除息日为 9 月 15 日（星期一）。这代表着每年 1.72 美元的股息和 0.3% 的股息收益率。赛默飞世尔科技的股息支付比率（DPR）目前为 9.95%。</p>
</div><h2>Insider Activity</h2>
<div class="lb-trans"><h2>内部活动</h2>
</div><ul>
<li>Top 4 Fastest Growing S&amp;P 500 Dividends: Buy, Sell, or Hold?</li>
</ul>
<div class="lb-trans"><ul>
<li>标普 500 中增长最快的 4 个股息：买入、卖出还是持有？</li>
</ul>
</div><p>In other news, CAO Joseph R. Holmes sold 385 shares of the firm's stock in a transaction that occurred on Friday, August 29th. The shares were sold at an average price of $492.63, for a total value of $189,662.55. Following the completion of the transaction, the chief accounting officer owned 2,319 shares of the company's stock, valued at approximately $1,142,408.97. This trade represents a 14.24% decrease in their ownership of the stock. The transaction was disclosed in a document filed with the SEC, which can be accessed through the SEC website. Also, EVP Gianluca Pettiti sold 400 shares of the firm's stock in a transaction that occurred on Friday, July 25th. The shares were sold at an average price of $479.98, for a total transaction of $191,992.00. Following the completion of the transaction, the executive vice president directly owned 22,367 shares of the company's stock, valued at approximately $10,735,712.66. The trade was a 1.76% decrease in their position. The disclosure for this sale can be found here. Over the last quarter, insiders sold 30,066 shares of company stock valued at $14,182,963. 0.33% of the stock is currently owned by company insiders.</p>
<div class="lb-trans"><p>在其他新闻中，首席会计官 Joseph R. Holmes 在 8 月 29 日（星期五）出售了 385 股公司的股票。股票以平均价格 492.63 美元出售，总价值为 189,662.55 美元。交易完成后，首席会计官持有 2,319 股公司股票，价值约为 1,142,408.97 美元。这笔交易代表其持股减少了 14.24%。该交易已在向 SEC 提交的文件中披露，相关文件可通过 SEC 网站访问。此外，执行副总裁 Gianluca Pettiti 在 7 月 25 日（星期五）出售了 400 股公司的股票。股票以平均价格 479.98 美元出售，总交易额为 191,992.00 美元。交易完成后，执行副总裁直接持有 22,367 股公司股票，价值约为 10,735,712.66 美元。这笔交易代表其持股减少了 1.76%。该销售的披露信息可以在这里找到。在上个季度，内部人士共出售了 30,066 股公司股票，价值为 14,182,963 美元。公司内部人士目前持有 0.33% 的股票。</p>
</div><h2>Wall Street Analysts Forecast Growth</h2>
<div class="lb-trans"><h2>华尔街分析师预测增长</h2>
</div><p>Several equities research analysts recently commented on TMO shares. William Blair began coverage on shares of Thermo Fisher Scientific in a report on Monday, August 18th. They issued an &#34;outperform&#34; rating for the company. Hsbc Global Res cut shares of Thermo Fisher Scientific from a &#34;strong-buy&#34; rating to a &#34;hold&#34; rating in a research report on Thursday, July 24th. Wells Fargo &amp; Company reduced their target price on shares of Thermo Fisher Scientific from $570.00 to $565.00 and set an &#34;overweight&#34; rating for the company in a research report on Thursday, July 24th. Raymond James Financial restated an &#34;outperform&#34; rating and set a $535.00 price objective (up from $525.00) on shares of Thermo Fisher Scientific in a research report on Thursday, July 24th. Finally, UBS Group raised their price objective on shares of Thermo Fisher Scientific from $460.00 to $500.00 and gave the stock a &#34;neutral&#34; rating in a research report on Thursday, July 24th. Fifteen investment analysts have rated the stock with a Buy rating and six have given a Hold rating to the company's stock. According to MarketBeat.com, the company has a consensus rating of &#34;Moderate Buy&#34; and a consensus target price of $590.60.</p>
<div class="lb-trans"><p>几位股票研究分析师最近对 TMO 股票发表了评论。William Blair 在 8 月 18 日星期一发布的报告中开始覆盖 Thermo Fisher Scientific 的股票，并给予该公司 “跑赢大盘” 的评级。汇丰全球研究在 7 月 24 日星期四的研究报告中将 Thermo Fisher Scientific 的股票评级从 “强力买入” 下调至 “持有”。富国银行在 7 月 24 日星期四的研究报告中将 Thermo Fisher Scientific 的目标价格从 570.00 美元下调至 565.00 美元，并给予该公司 “增持” 评级。Raymond James Financial 在 7 月 24 日星期四的研究报告中重申了 “跑赢大盘” 的评级，并将 Thermo Fisher Scientific 的目标价格设定为 535.00 美元（上调自 525.00 美元）。最后，瑞银集团在 7 月 24 日星期四的研究报告中将 Thermo Fisher Scientific 的目标价格从 460.00 美元上调至 500.00 美元，并给予该股票 “中性” 评级。十五位投资分析师对该股票给予了买入评级，六位分析师给予了持有评级。根据 MarketBeat.com 的数据，该公司的共识评级为 “适度买入”，共识目标价格为 590.60 美元。</p>
</div><p><strong>View Our Latest Stock Report on TMO</strong></p>
<div class="lb-trans"><p><strong>查看我们最新的 TMO 股票报告</strong></p>
</div><h2>Thermo Fisher Scientific Company Profile</h2>
<div class="lb-trans"><h2>Thermo Fisher Scientific 公司简介</h2>
</div><p>(Free Report)</p>
<div class="lb-trans"><p>（免费报告）</p>
</div><p>Thermo Fisher Scientific Inc provides life sciences solutions, analytical instruments, specialty diagnostics, and laboratory products and biopharma services in the North America, Europe, Asia-Pacific, and internationally. The company's Life Sciences Solutions segment offers reagents, instruments, and consumables for biological and medical research, discovery, and production of drugs and vaccines, as well as diagnosis of infections and diseases; and solutions include biosciences, genetic sciences, and bio production to pharmaceutical, biotechnology, agricultural, clinical, healthcare, academic, and government markets.</p>
<div class="lb-trans"><p>Thermo Fisher Scientific Inc 在北美、欧洲、亚太地区及国际市场提供生命科学解决方案、分析仪器、专业诊断、实验室产品和生物制药服务。该公司的生命科学解决方案部门为生物和医学研究、药物和疫苗的发现与生产，以及感染和疾病的诊断提供试剂、仪器和耗材；解决方案包括生物科学、遗传科学和生物生产，服务于制药、生物技术、农业、临床、医疗保健、学术和政府市场。</p>
</div><h2>Featured Articles</h2>
<div class="lb-trans"><h2>精选文章</h2>
</div><ul>
<li>Five stocks we like better than Thermo Fisher Scientific</li>
<li>Uptrend Stocks Explained: Learn How to Trade Using Uptrends</li>
<li>EA’s $55 Billion Deal Spurs a Shake-Up in the Gaming Sector</li>
<li>Insider Selling Explained: Can it Inform Your Investing Choices?</li>
<li>These Are the 3 Hottest Sectors for Q3 Earnings Growth</li>
<li>Insider Trading - What You Need to Know</li>
<li>AMD Could Double From Here—Thanks to Its Blockbuster OpenAI Deal</li>
</ul>
<div class="lb-trans"><ul>
<li>五只我们更看好的股票，胜过 Thermo Fisher Scientific</li>
<li>上升趋势股票解析：学习如何利用上升趋势进行交易</li>
<li>EA 的 550 亿美元交易引发游戏行业震荡</li>
<li>内部交易解析：它能否影响你的投资选择？</li>
<li>这些是第三季度盈利增长的三个热门行业</li>
<li>内幕交易 - 你需要知道的事项</li>
<li>AMD 可能会在此基础上翻倍——得益于其重磅的 OpenAI 交易</li>
</ul>
</div><p><strong>Want to see what other hedge funds are holding TMO?</strong> Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Thermo Fisher Scientific Inc. (NYSE:TMO - Free Report).</p>
<div class="lb-trans"><p><strong>想知道其他对 TMO 持有的对冲基金吗？</strong> 访问 HoldingsChannel.com 获取 Thermo Fisher Scientific Inc.（NYSE:TMO - 免费报告）的最新 13F 文件和内部交易。</p>
</div><p><img src="https://imageproxy.pbkrs.com/https://www.marketbeat.com/scripts/SECFilingChart.ashx/query-UHJlZml4PU5ZU0UmU3ltYm9sPVRNTw" alt="" original-src="https://www.marketbeat.com/scripts/SECFilingChart.ashx?Prefix=NYSE&amp;Symbol=TMO"/></p>
<p><em>This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.</em></p>
<div class="lb-trans"><p><em>此即时新闻提醒由叙述科学技术和 MarketBeat 的金融数据生成，以便为读者提供最快和最准确的报道。此故事在发布前已由 MarketBeat 的编辑团队审核。如对该故事有任何问题或意见，请发送至 contact@marketbeat.com。</em></p>
</div><h2>Should You Invest $1,000 in Thermo Fisher Scientific Right Now?</h2>
<div class="lb-trans"><h2>你现在应该投资 1000 美元在 Thermo Fisher Scientific 吗？</h2>
</div><p>Before you consider Thermo Fisher Scientific, you'll want to hear this.</p>
<div class="lb-trans"><p>在考虑 Thermo Fisher Scientific 之前，你需要听听这个。</p>
</div><p>MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Thermo Fisher Scientific wasn't on the list.</p>
<div class="lb-trans"><p>MarketBeat 每天跟踪华尔街顶级评级和表现最佳的研究分析师及其推荐给客户的股票。MarketBeat 已识别出五只顶级分析师悄悄向客户推荐的股票，建议在更广泛的市场注意到之前买入……而 Thermo Fisher Scientific 并不在名单上。</p>
</div><p>While Thermo Fisher Scientific currently has a Moderate Buy rating among analysts, top-rated analysts believe these five stocks are better buys.</p>
<div class="lb-trans"><p>虽然 Thermo Fisher Scientific 目前在分析师中获得了适度买入评级，但顶级分析师认为这五只股票更值得购买。</p>
</div><p>View The Five Stocks Here</p>
<div class="lb-trans"><p>查看这五只股票</p>
</div>

NBT Bank N A NY 出售了赛默飞世尔科技公司 $TMO 的股票